Sapropterin dihydrochloride contains not less than 98.0 percent and not more than 102.0 percent of labeled amount of C9H17Cl2N5O3

共有 1 個藥物證書使用此成份

"因華"鹽酸沙丙蝶呤
Sapropterin Dihydrochloride "InnoPharmax"

• 申請商: 因華生技製藥股份有限公司
• 適應症: 用於消化道和代謝產品。
• 發證日期: 2020-04-20